366 related articles for article (PubMed ID: 28601639)
1. Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice.
Wang Z; Wang S; Wang Z; Yun T; Wang C; Wang H
Biochem Biophys Res Commun; 2017 Aug; 490(2):194-201. PubMed ID: 28601639
[TBL] [Abstract][Full Text] [Related]
2. Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE
Zhou Y; Chen R; Liu D; Wu C; Guo P; Lin W
Mar Drugs; 2017 Nov; 15(11):. PubMed ID: 29135917
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
[TBL] [Abstract][Full Text] [Related]
4. Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice.
Dong P; Pan L; Zhang X; Zhang W; Wang X; Jiang M; Chen Y; Duan Y; Wu H; Xu Y; Zhang P; Zhu Y
J Ethnopharmacol; 2017 Feb; 198():479-488. PubMed ID: 28119096
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
6. Kuwanon G attenuates atherosclerosis by upregulation of LXRα-ABCA1/ABCG1 and inhibition of NFκB activity in macrophages.
Liu XX; Zhang XW; Wang K; Wang XY; Ma WL; Cao W; Mo D; Sun Y; Li XQ
Toxicol Appl Pharmacol; 2018 Feb; 341():56-63. PubMed ID: 29355567
[TBL] [Abstract][Full Text] [Related]
7. Genetic and Pharmacologic Inhibition of the Neutrophil Elastase Inhibits Experimental Atherosclerosis.
Wen G; An W; Chen J; Maguire EM; Chen Q; Yang F; Pearce SWA; Kyriakides M; Zhang L; Ye S; Nourshargh S; Xiao Q
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437605
[TBL] [Abstract][Full Text] [Related]
8. Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.
Zhao JF; Shyue SK; Kou YR; Lu TM; Lee TS
Int J Biol Sci; 2016; 12(7):812-23. PubMed ID: 27313495
[TBL] [Abstract][Full Text] [Related]
9. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
10. Enhancing PPARγ by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice.
Gao Q; Wei A; Chen F; Chen X; Ding W; Ding Z; Wu Z; Du R; Cao W
Pharmacol Res; 2020 Oct; 160():105059. PubMed ID: 32621955
[TBL] [Abstract][Full Text] [Related]
11. EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1.
Tsai JY; Su KH; Shyue SK; Kou YR; Yu YB; Hsiao SH; Chiang AN; Wu YL; Ching LC; Lee TS
Cardiovasc Res; 2010 Dec; 88(3):415-23. PubMed ID: 20615914
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase.
Sukhanov S; Snarski P; Vaughn C; Lobelle-Rich P; Kim C; Higashi Y; Shai SY; Delafontaine P
Atherosclerosis; 2015 Feb; 238(2):313-20. PubMed ID: 25549319
[TBL] [Abstract][Full Text] [Related]
13. [Huanglian jiedu decoction regulated and controlled differentiation of monocytes, macrophages, and foam cells: an experimental study].
Li T; Han JY; Wang BB; Chen B; Li YM; Yu ZJ; Xue X; Zhang JP; Wang XB; Zeng H; Ma YL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Sep; 34(9):1096-102. PubMed ID: 25335334
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional supramolecular nanofiber inhibits atherosclerosis by enhancing plaque stability and anti-inflammation in apoE
Shang Y; Ma C; Zhang J; Wang Z; Ren C; Luo X; Peng R; Liu J; Mao J; Shi Y; Fan G
Theranostics; 2020; 10(22):10231-10244. PubMed ID: 32929345
[No Abstract] [Full Text] [Related]
15. UFM1 Protects Macrophages from oxLDL-Induced Foam Cell Formation Through a Liver X Receptor α Dependent Pathway.
Pang Q; Xiong J; Hu XL; He JP; Liu HF; Zhang GY; Li YY; Chen FL
J Atheroscler Thromb; 2015; 22(11):1124-40. PubMed ID: 26040753
[TBL] [Abstract][Full Text] [Related]
16. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
17. 11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ mice.
García RA; Search DJ; Lupisella JA; Ostrowski J; Guan B; Chen J; Yang WP; Truong A; He A; Zhang R; Yan M; Hellings SE; Gargalovic PS; Ryan CS; Watson LM; Langish RA; Shipkova PA; Carson NL; Taylor JR; Yang R; Psaltis GC; Harrity TW; Robl JA; Gordon DA
PLoS One; 2013; 8(2):e53192. PubMed ID: 23383297
[TBL] [Abstract][Full Text] [Related]
18. Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice.
Dai XY; Cai Y; Mao DD; Qi YF; Tang C; Xu Q; Zhu Y; Xu MJ; Wang X
J Mol Cell Cardiol; 2012 Oct; 53(4):509-20. PubMed ID: 22841663
[TBL] [Abstract][Full Text] [Related]
19. IL-33 reduces macrophage foam cell formation.
McLaren JE; Michael DR; Salter RC; Ashlin TG; Calder CJ; Miller AM; Liew FY; Ramji DP
J Immunol; 2010 Jul; 185(2):1222-9. PubMed ID: 20543107
[TBL] [Abstract][Full Text] [Related]
20. Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation: understanding the lipid paradox associated with rheumatoid arthritis.
Pérez-Baos S; Barrasa JI; Gratal P; Larrañaga-Vera A; Prieto-Potin I; Herrero-Beaumont G; Largo R
Br J Pharmacol; 2017 Sep; 174(18):3018-3031. PubMed ID: 28646516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
